- Home
- Publications
- Publication Search
- Publication Details
Title
BACE2 degradation mediated by the macroautophagy-lysosome pathway
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROSCIENCE
Volume 37, Issue 12, Pages 1970-1977
Publisher
Wiley
Online
2013-06-17
DOI
10.1111/ejn.12204
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Entering the lysosome through a transient gate by chaperone-mediated autophagy
- (2014) Urmi Bandyopadhyay et al. Autophagy
- Neuronal autophagy and neurodegenerative diseases
- (2012) Jin H. Son et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis
- (2012) Yili Wu et al. FASEB JOURNAL
- Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
- (2012) Philip T.T. Ly et al. JOURNAL OF CLINICAL INVESTIGATION
- Chaperone-mediated autophagy: a unique way to enter the lysosome world
- (2012) Susmita Kaushik et al. TRENDS IN CELL BIOLOGY
- Macroautophagy-generated increase of lysosomal amyloid β-protein mediates oxidant-induced apoptosis of cultured neuroblastoma cells
- (2011) Lin Zheng et al. Autophagy
- Chasing the elusive mammalian microautophagy
- (2011) Laura Santambrogio et al. Autophagy
- Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
- (2011) Chia-Hsiung Chen et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Regulation of RCAN1 Protein Activity by Dyrk1A Protein-mediated Phosphorylation
- (2011) Min-Su Jung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulator of Calcineurin 1 (RCAN1) Facilitates Neuronal Apoptosis through Caspase-3 Activation
- (2011) Xiulian Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SOD1 (Copper/Zinc Superoxide Dismutase) Deficiency Drives Amyloid β Protein Oligomerization and Memory Loss in Mouse Model of Alzheimer Disease
- (2011) Kazuma Murakami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of β-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer’s Disease
- (2011) Xiulian Sun et al. JOURNAL OF NEUROCHEMISTRY
- Distinct Roles In Vivo for the Ubiquitin-Proteasome System and the Autophagy-Lysosomal Pathway in the Degradation of -Synuclein
- (2011) D. Ebrahimi-Fakhari et al. JOURNAL OF NEUROSCIENCE
- Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn)
- (2011) S. Batelli et al. NEUROSCIENCE
- Protective Effects of Positive Lysosomal Modulation in Alzheimer's Disease Transgenic Mouse Models
- (2011) David Butler et al. PLoS One
- In vivo effects of APP are not exacerbated by BACE2 co-overexpression: behavioural characterization of a double transgenic mouse model
- (2010) Garikoitz Azkona et al. AMINO ACIDS
- Autophagy and misfolded proteins in neurodegeneration
- (2010) Daniel J. Metcalf et al. EXPERIMENTAL NEUROLOGY
- Unknown
- (2010) Michael Bacher et al. MOLECULAR MEDICINE
- Integration of Clearance Mechanisms: The Proteasome and Autophagy
- (2010) E. Wong et al. Cold Spring Harbor Perspectives in Biology
- Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways
- (2009) Heng Liu et al. FASEB JOURNAL
- Characterization of a mouse model overexpressing beta-site APP-cleaving enzyme 2 reveals a new role for BACE2
- (2009) G. Azkona et al. GENES BRAIN AND BEHAVIOR
- TMP21 degradation is mediated by the ubiquitin-proteasome pathway
- (2008) Shengchun Liu et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Chaperone-Mediated Autophagy Receptor Organizes in Dynamic Protein Complexes at the Lysosomal Membrane
- (2008) U. Bandyopadhyay et al. MOLECULAR AND CELLULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More